After trading closed yesterday, Exelixis revealed that the US Food and Drug Administration (FDA) has notified the company ...
The Down syndrome treatment market in the USA is valued at nearly $250 million, with companies like Aelis Farma, AC Immune, ...
FDA accepts Satsuma Pharmaceuticals' NDA resubmission for STS101 migraine drug. Hovione expands facilities in Ireland and New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback